Unistin is a medication used to treat certain types of cancer, such as lymphoma and ovarian cancer. It contains melphalan, which belongs to the alkylating agent group and works to destroy cancer cells by interfering with DNA and preventing cell division. It is used either orally or intravenously, depending on the patient's condition and the treatment plan developed by the specialist doctor. The patient requires regular monitoring during the treatment period, as
Unistin may cause a decrease in the number of white blood cells and platelets, which increases the risk of infection and bleeding. It may also cause nausea, fatigue, and disturbances in kidney function. Therefore, tests must be monitored regularly. This medication should not be used during pregnancy or breastfeeding. The doctor must be informed of all other medications being taken to avoid serious drug interactions.